1989
DOI: 10.1016/0022-4731(89)90426-3
|View full text |Cite
|
Sign up to set email alerts
|

Radioimmunoassay of plasma 21-deoxycortisol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
5
0
1

Year Published

1990
1990
2008
2008

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 26 publications
1
5
0
1
Order By: Relevance
“…In contrast, clearly different behaviour was observed for heterozygous carriers (numbers 1, 3 and 4, Table 1) in which the level of 21‐DF strongly increased (about 10–15 times) after ACTH stimulation. These results fully confirm the literature data obtained by using the radioimmunoassay technique 8–10,13,14…”
Section: Resultssupporting
confidence: 91%
See 2 more Smart Citations
“…In contrast, clearly different behaviour was observed for heterozygous carriers (numbers 1, 3 and 4, Table 1) in which the level of 21‐DF strongly increased (about 10–15 times) after ACTH stimulation. These results fully confirm the literature data obtained by using the radioimmunoassay technique 8–10,13,14…”
Section: Resultssupporting
confidence: 91%
“…It is known that ACTH induces much higher 21‐DF plasma levels in heterozygous than in normal subjects 8–12. Several studies8–10,13–15 have demonstrated that 21‐DF is a more sensitive marker than 17‐OHP because it allows the detection of more than 90% of heterozygous carriers. Plasma levels of 21‐DF before and 60 min after ACTH stimulation is becoming a new approach for detection of heterozygous carriers of 21‐OHD.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Although 17-hydroxyprogesterone and 11-desoxycortisol are the most used markers to diagnose CAH defects, the use of other steroids from C21-steroid metabolic pathway is relatively unexplored, mainly due to the lack of practical methodologies. 21-Desoxycortisol has been described as a more sensitive marker than 17-hydroxyprogesterone for 21-hydroxylase deficiency detection and its determination after ACTH stimulation is becoming the new strategy for the identification of heterozygote carriers of an impaired 21-hydroxylase gene [27][28][29]. Increased 11-desoxycorticosterone levels may signal a mineralocorticoid excess in situations when aldosterone levels remain within the normal limits and it is a specific marker of the mineralocorticoid pathway [5,30].…”
Section: Discussionmentioning
confidence: 98%
“…Because 11␤-hydroxylation is confined to the adrenal cortex, in contrast to 21-hydroxylase, 21DF does not follow the same secretory pattern of 17OHP; its levels do not change with either puberty or the menstrual cycle (7,8,34). Thus, in the pubertal patient with 21OHD, 21DF may be useful for therapeutic decisions.…”
Section: Discussionmentioning
confidence: 83%